Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (61-70 of 4,096) with videos related to

Pageof 410
Sort By:
Cancer Cell|May 5, 2023
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapyMark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, et al.
Cancer Cell|May 9, 2023
Meet the authors: Dr. Clint Allen and Dr. Sandro SantagataClint Allen, Sandro Santagata
Cancer Cell|May 19, 2023
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)Yunpeng Yang, Jianji Pan, Hui Wang, et al.
Cancer Cell|June 23, 2015
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing MicrotubulesYu Yu, Stephanie Gaillard, Jude M Phillip, et al.
Cancer Cell|August 2, 2016
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and MetastasisLu Wang, Zibo Zhao, Mark B Meyer, et al.
Cancer Cell|July 7, 2015
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical ModelsHelen Y Zou, Luc Friboulet, David P Kodack, et al.
Cancer Cell|June 2, 2015
Dysfunction of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer MetastasisWenzhe Si, Wei Huang, Yu Zheng, et al.
Cancer Cell|August 16, 2016
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF SignalingZoi Karoulia, Yang Wu, Tamer A Ahmed, et al.
Cancer Cell|January 10, 2018
A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid LeukemiaYali Xu, Joseph P Milazzo, Tim D D Somerville, et al.
Cancer Cell|January 10, 2018
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaA Gordon Robertson, Juliann Shih, Christina Yau, et al.
Pageof 410

Showing results (61-70 of 4,096) with videos related to

Sort By:
Pageof 410
Cancer Cell|May 5, 2023
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapyMark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, et al.
Cancer Cell|May 9, 2023
Meet the authors: Dr. Clint Allen and Dr. Sandro SantagataClint Allen, Sandro Santagata
Cancer Cell|May 19, 2023
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)Yunpeng Yang, Jianji Pan, Hui Wang, et al.
Cancer Cell|June 23, 2015
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing MicrotubulesYu Yu, Stephanie Gaillard, Jude M Phillip, et al.
Cancer Cell|August 2, 2016
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and MetastasisLu Wang, Zibo Zhao, Mark B Meyer, et al.
Cancer Cell|July 7, 2015
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical ModelsHelen Y Zou, Luc Friboulet, David P Kodack, et al.
Cancer Cell|June 2, 2015
Dysfunction of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer MetastasisWenzhe Si, Wei Huang, Yu Zheng, et al.
Cancer Cell|August 16, 2016
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF SignalingZoi Karoulia, Yang Wu, Tamer A Ahmed, et al.
Cancer Cell|January 10, 2018
A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid LeukemiaYali Xu, Joseph P Milazzo, Tim D D Somerville, et al.
Cancer Cell|January 10, 2018
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaA Gordon Robertson, Juliann Shih, Christina Yau, et al.
Pageof 410